Chondroitin sulfate proteoglycans (CSPGs) inhibit repair following spinal cord injury. Here we use mammalian-compatible engineered chondroitinase ABC (ChABC) delivered via lentiviral vector (LV-ChABC) to explore the consequences of large-scale CSPG digestion for spinal cord repair. We demonstrate significantly reduced secondary injury pathology in adult rats following spinal contusion injury and LV-ChABC treatment, with reduced cavitation and enhanced preservation of spinal neurons and axons at 12 weeks postinjury, compared with control (LV-GFP)-treated animals. To understand these neuroprotective effects, we investigated early inflammatory changes following LV-ChABC treatment. Increased expression of the phagocytic macrophage marker CD68 a...
Traumatic spinal cord injuries (SCIs) affect millions of people worldwide; the majority of whom are ...
Chondroitin sulfate proteoglycans (CSPGs) present a formidable barrier to regrowing axons following ...
Chondroitin sulfate proteoglycans (CSPGs) present a formidable barrier to regrowing axons following ...
Chondroitin sulfate proteoglycans (CSPGs) inhibit repair following spinal cord injury. Here we use m...
Chondroitin sulfate proteoglycans (CSPGs) inhibit repair following spinal cord injury. Here we use m...
AbstractChondroitin sulphate proteoglycans (CSPGs) are known to be important contributors to the int...
The inability of axons to regenerate after a spinal cord injury in the adult mammalian central nervo...
Chondroitin sulfate proteoglycans (CSPGs) act as potent inhibitors of axonal growth and neuroplastic...
<div><p>Chondroitin sulfate proteoglycans (CSPGs) are glial scar-associated molecules considered axo...
Chondroitin sulfate proteoglycans (CSPGs) are glial scar-associated molecules considered axonal rege...
Chondroitinase ABC is a promising preclinical therapy that promotes functional neuroplasticity after...
Session 4: Proteoglycans Inflammation and Signaling: PO11The microenvironment of the injured spinal ...
International audienceUpregulation of extracellular chondroitin sulfate proteoglycans (CSPG) is a pr...
The adult spinal cord harbours a population of multipotent neural precursor cells (NPCs) with the ab...
We have previously demonstrated that enzymatic digestion of chondroitin sulfate proteoglycan (CSPG) ...
Traumatic spinal cord injuries (SCIs) affect millions of people worldwide; the majority of whom are ...
Chondroitin sulfate proteoglycans (CSPGs) present a formidable barrier to regrowing axons following ...
Chondroitin sulfate proteoglycans (CSPGs) present a formidable barrier to regrowing axons following ...
Chondroitin sulfate proteoglycans (CSPGs) inhibit repair following spinal cord injury. Here we use m...
Chondroitin sulfate proteoglycans (CSPGs) inhibit repair following spinal cord injury. Here we use m...
AbstractChondroitin sulphate proteoglycans (CSPGs) are known to be important contributors to the int...
The inability of axons to regenerate after a spinal cord injury in the adult mammalian central nervo...
Chondroitin sulfate proteoglycans (CSPGs) act as potent inhibitors of axonal growth and neuroplastic...
<div><p>Chondroitin sulfate proteoglycans (CSPGs) are glial scar-associated molecules considered axo...
Chondroitin sulfate proteoglycans (CSPGs) are glial scar-associated molecules considered axonal rege...
Chondroitinase ABC is a promising preclinical therapy that promotes functional neuroplasticity after...
Session 4: Proteoglycans Inflammation and Signaling: PO11The microenvironment of the injured spinal ...
International audienceUpregulation of extracellular chondroitin sulfate proteoglycans (CSPG) is a pr...
The adult spinal cord harbours a population of multipotent neural precursor cells (NPCs) with the ab...
We have previously demonstrated that enzymatic digestion of chondroitin sulfate proteoglycan (CSPG) ...
Traumatic spinal cord injuries (SCIs) affect millions of people worldwide; the majority of whom are ...
Chondroitin sulfate proteoglycans (CSPGs) present a formidable barrier to regrowing axons following ...
Chondroitin sulfate proteoglycans (CSPGs) present a formidable barrier to regrowing axons following ...